Epigenetics & Gene Expression 表观遗传与基因表达

Introduction：What Is Gene Expression？

Gene expression is the process by which the information encoded in a gene is used to synthesise a functional gene product ： typically a protein, but sometimes a non-coding RNA. In multicellular organisms, nearly every somatic cell contains the same complete genome, yet a neurone looks and functions nothing like a hepatocyte. This cellular diversity arises not from differences in DNA sequence, but from differential gene expression：some genes are switched on in certain cell types and switched off in others. Understanding how this selective activation and silencing is controlled lies at the heart of developmental biology, physiology, and increasingly, personalised medicine.

基因表达是指基因中编码的信息被用于合成功能性基因产物（通常是蛋白质，有时是非编码 RNA）的过程。在多细胞生物中，几乎每个体细胞都包含相同的完整基因组，但神经元与肝细胞的外观和功能截然不同。这种细胞多样性并非源于 DNA 序列的差异，而是源于差异基因表达：某些基因在特定细胞类型中被开启，在其他细胞类型中被关闭。理解这种选择性激活和沉默的控制机制，是发育生物学、生理学以及日益重要的个性化医学的核心问题。

Transcriptional Control：Promoters and Transcription Factors

At the heart of gene regulation lies transcriptional control ： the decision of whether and how often a gene is transcribed into mRNA. RNA polymerase II binds to a promoter region immediately upstream of the coding sequence, but this binding alone is weak and non-specific. Transcription factors (TFs) are proteins that recognise specific DNA sequences within the promoter or enhancer regions and either activate or repress transcription. Activator proteins recruit the transcriptional machinery through interactions with the mediator complex, while repressor proteins block the binding of activators or the polymerase itself. In eukaryotes, the coordinated action of multiple TFs ： each binding to its cognate short DNA motif ： integrates signals from developmental cues, hormones, and the environment to fine-tune gene output.

基因调控的核心在于转录控制：即决定一个基因是否转录为 mRNA 以及转录频率。RNA 聚合酶 II 与编码序列上游的启动子区域结合，但这种单独的结合是弱且非特异性的。转录因子是能够识别启动子或增强子区域内特定 DNA 序列的蛋白质，它们可以激活或抑制转录。激活蛋白通过与中介体复合物的相互作用招募转录机器，而抑制蛋白则阻断激活子或聚合酶本身的结合。在真核生物中，多种转录因子的协同作用：每种因子结合其同源短 DNA 基序：整合了来自发育信号、激素和环境的信号，以精细调节基因输出。

Epigenetics：Heritable Changes Without DNA Sequence Alteration

Epigenetics refers to heritable changes in gene expression that do not involve changes to the underlying DNA nucleotide sequence. These modifications can be stably transmitted through mitotic cell divisions and, in some cases, across generations. The two best-characterised epigenetic mechanisms are DNA methylation and histone modification, both of which alter chromatin structure and accessibility without rewriting the genetic code. Crucially, epigenetic marks are reversible ： this plasticity makes them attractive therapeutic targets, particularly in oncology where tumour-suppressor genes are frequently silenced by aberrant hypermethylation rather than by mutation.

表观遗传学指的是不涉及底层 DNA 核苷酸序列变化的基因表达的可遗传变化。这些修饰可以通过有丝分裂细胞分裂稳定传递，在某些情况下甚至可以跨代遗传。两个研究最为深入的表观遗传机制是 DNA 甲基化和组蛋白修饰，它们都改变染色质结构和可及性，而不重写遗传密码。关键的是，表观遗传标记是可逆的：这种可塑性使其成为有吸引力的治疗靶点，特别是在肿瘤学中，抑癌基因常常因异常高甲基化而非突变被沉默。

DNA Methylation：The Silencing Mark

DNA methylation involves the covalent addition of a methyl group (−CH₃) to the 5′ position of cytosine, predominantly within CpG dinucleotides. These CpG sites are not uniformly distributed; they cluster in regions called CpG islands, which are frequently found near gene promoters. When a promoter CpG island becomes hypermethylated, methyl-CpG-binding domain (MBD) proteins recruit histone deacetylases and other chromatin-remodelling complexes, compacting the chromatin and physically blocking transcription factor access. This mechanism explains, for example, why the inactivated X chromosome in female mammals (the Barr body) is heavily methylated and transcriptionally silent across almost its entire length.

DNA 甲基化涉及在胞嘧啶的 5′ 位点上共价添加一个甲基基团（−CH₃），主要发生在 CpG 二核苷酸中。这些 CpG 位点并非均匀分布；它们聚集在称为 CpG 岛的区域，这些区域常位于基因启动子附近。当启动子 CpG 岛发生高甲基化时，甲基 CpG 结合域（MBD）蛋白招募组蛋白去乙酰化酶和其他染色质重塑复合物，压缩染色质并在物理上阻断转录因子的接触。这一机制解释了为什么雌性哺乳动物中失活的 X 染色体（巴氏小体）几乎在其整个长度上被高度甲基化且转录沉默。

Histone Modification and Chromatin Remodelling

Histones are the protein spools around which DNA wraps to form nucleosomes ： the fundamental repeating unit of chromatin. Each histone octamer (two copies each of H2A, H2B, H3, and H4) has N-terminal tails that protrude from the nucleosome core and are subject to a vast array of post-translational modifications：acetylation, methylation, phosphorylation, ubiquitination, and more. Acetylation of lysine residues by histone acetyltransferases (HATs) neutralises the positive charge, relaxing chromatin into an open euchromatin conformation accessible to the transcriptional machinery. Conversely, deacetylation by histone deacetylases (HDACs) restores the positive charge and promotes a closed heterochromatin state. The combinatorial nature of these modifications ： often called the histone code ： means that a single nucleosome can simultaneously carry activating marks such as H3K4me3 and repressive marks such as H3K27me3, reflecting a poised or bivalent chromatin state characteristic of embryonic stem cells.

组蛋白是 DNA 缠绕的蛋白质线轴，形成核小体：染色质的基本重复单位。每个组蛋白八聚体（H2A、H2B、H3 和 H4 各两份拷贝）具有从核小体核心突出的 N 端尾部，这些尾部受到大量翻译后修饰的影响：乙酰化、甲基化、磷酸化、泛素化等。组蛋白乙酰转移酶（HAT）对赖氨酸残基的乙酰化中和了正电荷，将染色质松弛为开放的常染色质构象，使转录机器可以接触。相反，组蛋白去乙酰化酶（HDAC）的去乙酰化恢复了正电荷，促进封闭的异染色质状态。这些修饰的组合性质：通常称为组蛋白密码：意味着单个核小体可以同时携带激活标记（如 H3K4me3）和抑制标记（如 H3K27me3），反映了胚胎干细胞特有的平衡或二价染色质状态。

RNA Interference：Post-Transcriptional Silencing

Small non-coding RNA molecules provide an additional layer of gene regulation at the post-transcriptional level. Small interfering RNAs (siRNAs) are typically exogenous in origin ： introduced by viral infection or experimental manipulation ： and guide the RNA-induced silencing complex (RISC) to complementary mRNA targets, triggering their cleavage and degradation. MicroRNAs (miRNAs), by contrast, are endogenous genome-encoded hairpin transcripts processed by the enzymes Drosha and Dicer. A single miRNA can regulate hundreds of mRNA targets through imperfect base-pairing, primarily by blocking translation or promoting deadenylation, making the miRNA regulatory network extraordinarily complex and influential in processes ranging from cell cycle control to apoptosis.

小非编码 RNA 分子在转录后水平提供了额外一层的基因调控。小干扰 RNA（siRNA）通常是外源的：由病毒感染或实验操作引入：并引导 RNA 诱导沉默复合物（RISC）至互补的 mRNA 靶标，触发其切割和降解。相比之下，微小 RNA（miRNA）是内源性基因组编码的发夹转录本，由 Drosha 和 Dicer 酶加工处理。单个 miRNA 可以通过不完全碱基配对调控数百个 mRNA 靶标，主要通过阻断翻译或促进脱腺苷酸化，使得 miRNA 调控网络异常复杂，并在从细胞周期控制到凋亡的过程中发挥重要影响。

Stem Cells and Differential Gene Expression

Stem cells embody the principle of differential gene expression with exceptional clarity. Totipotent cells of the early morula can give rise to all embryonic and extra-embryonic tissues; pluripotent embryonic stem cells can produce any cell type of the three germ layers but not extra-embryonic structures; and multipotent adult stem cells are restricted to lineages within a single tissue. At each step of commitment, transcription factors such as Oct4, Sox2, and Nanog ： the core pluripotency network ： are progressively silenced while lineage-specific master regulators such as MyoD (muscle) or Pax6 (eye) are activated. Epigenetic modifications lock in these decisions：promoters of pluripotency genes become methylated, while bivalent domains resolve by losing one of their two opposing marks.

干细胞以异常清晰的方式体现了差异基因表达的原理。早期桑葚胚的全能细胞可以产生所有胚胎和胚外组织；多能胚胎干细胞可以产生三个胚层的任何细胞类型，但不能产生胚外结构；而多能成体干细胞被限制在单一组织内的谱系中。在命运的每一步，核心多能性网络中的转录因子：如 Oct4、Sox2 和 Nanog：被逐步沉默，而谱系特异性的主调控因子如 MyoD（肌肉）或 Pax6（眼睛）被激活。表观遗传修饰锁定了这些决定：多能性基因的启动子被甲基化，而二价结构域通过失去其两个对立标记中的一个得以解析。

Epigenetics and Disease

The clinical relevance of epigenetics is perhaps most starkly illustrated in cancer. Tumour cells exhibit global DNA hypomethylation ： which promotes genomic instability and the activation of transposable elements ： alongside focal hypermethylation of CpG islands in tumour-suppressor gene promoters such as p16, BRCA1, and MLH1. This dual pattern simultaneously activates oncogenes and silences protective mechanisms. Importantly, unlike mutations, epigenetic silencing is pharmacologically reversible：HDAC inhibitors such as vorinostat and DNA methyltransferase inhibitors such as azacitidine are already approved for treating myelodysplastic syndromes and certain lymphomas, validating the therapeutic promise of epigenetic drugs.

表观遗传学的临床相关性在癌症中表现得最为鲜明。肿瘤细胞表现出全基因组 DNA 低甲基化：这促进了基因组不稳定性和转座因子的激活：同时伴有抑癌基因启动子（如 p16、BRCA1 和 MLH1）CpG 岛的局灶性高甲基化。这种双重模式同时激活癌基因并沉默保护机制。重要的是，与突变不同，表观遗传沉默在药理上是可逆的：HDAC 抑制剂（如 vorinostat）和 DNA 甲基转移酶抑制剂（如 azacitidine）已被批准用于治疗骨髓增生异常综合征和某些淋巴瘤，验证了表观遗传药物的治疗前景。

Environmental Influences on the Epigenome

One of the most compelling aspects of epigenetics is its responsiveness to environmental inputs. Diet, stress, toxins, and even maternal behaviour during critical developmental windows can leave lasting epigenetic marks. The classic experimental demonstration comes from agouti mice：supplementing the maternal diet with methyl donors such as folic acid and vitamin B12 shifts the coat colour and metabolic health of offspring by increasing methylation at the agouti locus. In humans, the Dutch Hunger Winter cohort provided epidemiological evidence that prenatal famine exposure altered DNA methylation patterns at the IGF2 gene decades later, linking early-life nutrition to adult metabolic disease risk through epigenetic mechanisms.

表观遗传学最引人注目的方面之一是其对环境输入的响应性。饮食、压力、毒素，甚至关键发育窗口期的母体行为都可以留下持久的表观遗传印记。经典的实验证明来自刺鼠：在母鼠饮食中补充甲基供体（如叶酸和维生素 B12）通过增加刺鼠位点的甲基化，改变了后代的毛色和代谢健康。在人类中，荷兰饥荒冬季队列提供了流行病学证据，表明产前饥荒暴露在数十年后改变了 IGF2 基因的 DNA 甲基化模式，通过表观遗传机制将早期生命营养与成年代谢疾病风险联系起来。

Key Bilingual Terms 关键双语术语

Gene expression · 基因表达 | Transcription factor · 转录因子 | Promoter · 启动子 | Epigenetics · 表观遗传学 | DNA methylation · DNA 甲基化 | CpG island · CpG 岛 | Histone modification · 组蛋白修饰 | Acetylation · 乙酰化 | Euchromatin · 常染色质 | Heterochromatin · 异染色质 | siRNA · 小干扰 RNA | miRNA · 微小RNA | RISC · RNA 诱导沉默复合物 | Pluripotency · 多能性 | Bivalent domain · 二价结构域 | HDAC inhibitor · 组蛋白去乙酰化酶抑制剂 | Stem cell · 干细胞 | Methyl donor · 甲基供体

Exam Tips 考试技巧

When answering epigenetics questions in A-Level Biology, always distinguish clearly between genetic and epigenetic changes：the former involve alterations to the DNA nucleotide sequence (mutations), while the latter modify gene expression without changing the sequence. A common mark-scoring phrase is “epigenetic modifications affect the accessibility of DNA to transcription factors and RNA polymerase.” For DNA methylation, remember to specify that it occurs at CpG sites in promoter regions and that increased methylation correlates with transcriptional silencing. For histone acetylation, link the neutralisation of positive charge to decreased histone-DNA affinity and chromatin relaxation. In essays on stem cells, explicitly name Oct4, Sox2, and Nanog as the core pluripotency transcription factors and explain how their silencing during differentiation is reinforced by promoter methylation ： this demonstrates understanding of the interplay between transcriptional and epigenetic control.

在 A-Level 生物学中回答表观遗传学问题时，始终清晰区分遗传变化和表观遗传变化：前者涉及 DNA 核苷酸序列的改变（突变），而后者在不改变序列的情况下修饰基因表达。一个常见的得分短语是”表观遗传修饰影响 DNA 对转录因子和 RNA 聚合酶的可及性”。对于 DNA 甲基化，记得说明它发生在启动子区域的 CpG 位点上，甲基化程度增加与转录沉默相关。对于组蛋白乙酰化，将正电荷的中和与组蛋白-DNA 亲和力降低和染色质松弛联系起来。在关于干细胞的论文中，明确命名 Oct4、Sox2 和 Nanog 为核心多能性转录因子，并解释它们在分化过程中的沉默是如何通过启动子甲基化得以强化的：这展示了对转录控制和表观遗传控制之间相互作用的理解。